Literature DB >> 18203138

Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.

Sam Collins1, Michael A Lutz, Paul E Zarek, Robert A Anders, Gilbert J Kersh, Jonathan D Powell.   

Abstract

TCR-induced NF-AT activation leads to the up-regulation of multiple genes involved in T cell anergy. Since NF-AT is also involved in T cell activation, we have endeavored to dissect TCR-induced activating and inhibitory genetic programs. This approach revealed roles for the early growth response (Egr) family of transcription factors and the Egr coactivator/corepressor NGFI-A-binding protein (NAB)2 in regulating T cell function. TCR-induced Egr-1 and NAB2 enhance T cell function, while Egr-2 and Egr-3 inhibit T cell function. In this report, we demonstrate that Egr-2 and Egr-3 are induced by NF-AT in the absence of AP-1, while Egr-1 and NAB2 both require AP-1-mediated transcription. Our data suggest that Egr-3 is upstream of Egr-2, and that mechanistically Egr-2 and Egr-3 suppress Egr-1 and NAB2 expression. Functionally, T cells from Egr-2 and Egr-3 null mice are hyperresponsive while T cells from Egr-3 transgenic, overexpressing mice are hyporesponsive. Furthermore, an in vivo model of autoimmune pneumonitis reveals that T cells from Egr-3 null mice hasten death while Egr-3-overexpressing T cells cause less disease. Overall, our data suggest that just as the Egr/NAB network of genes control cell fate in other systems, TCR-induced Egr-1, 2, 3 and NAB2 control the fate of antigen recognition in T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203138      PMCID: PMC3598016          DOI: 10.1002/eji.200737157

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

1.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.

Authors:  Vigo Heissmeyer; Fernando Macián; Sin-Hyeog Im; Rajat Varma; Stefan Feske; K Venuprasad; Hua Gu; Yun-Cai Liu; Michael L Dustin; Anjana Rao
Journal:  Nat Immunol       Date:  2004-02-15       Impact factor: 25.606

2.  Role of LAG-3 in regulatory T cells.

Authors:  Ching-Tai Huang; Creg J Workman; Dallas Flies; Xiaoyu Pan; Aimee L Marson; Gang Zhou; Edward L Hipkiss; Sowmya Ravi; Jeanne Kowalski; Hyam I Levitsky; Jonathan D Powell; Drew M Pardoll; Charles G Drake; Dario A A Vignali
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

3.  Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription.

Authors:  Samuel Collins; Lawrence A Wolfraim; Charles G Drake; Maureen R Horton; Jonathan D Powell
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

4.  NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli.

Authors:  J Svaren; B R Sevetson; E D Apel; D B Zimonjic; N C Popescu; J Milbrandt
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Induction of the early growth response (Egr) family of transcription factors during thymic selection.

Authors:  H Shao; D H Kono; L Y Chen; E M Rubin; J Kaye
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

6.  Mader: a novel nuclear protein over expressed in human melanomas.

Authors:  K H Kirsch; Y Korradi; J P Johnson
Journal:  Oncogene       Date:  1996-03-07       Impact factor: 9.867

7.  Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.

Authors:  Hongkang Xi; Gilbert J Kersh
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

8.  Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression.

Authors:  Eva L Decker; Nina Nehmann; Eva Kampen; Hermann Eibel; Peter F Zipfel; Christine Skerka
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

9.  Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription.

Authors:  M W Russo; B R Sevetson; J Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

10.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

View more
  53 in total

1.  Genetic background-dependent role of Egr1 for eyelid development.

Authors:  Jangsuk Oh; Yujuan Wang; Shida Chen; Peng Li; Ning Du; Zu-Xi Yu; Donna Butcher; Tesfay Gebregiorgis; Erin Strachan; Ordan J Lehmann; Brian P Brooks; Chi-Chao Chan; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-04       Impact factor: 11.205

2.  The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.

Authors:  Feng Fang; Kohtaro Ooka; Swati Bhattacharyya; Swati Bhattachyya; Jun Wei; Minghua Wu; Pan Du; Simon Lin; Francesco Del Galdo; Carol A Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 3.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

Review 4.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

5.  EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.

Authors:  Joerg Kumbrink; Kathrin H Kirsch; Judith P Johnson
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

6.  Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.

Authors:  David N Boone; Ying Qi; Zhaoliang Li; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

7.  The Myc-ARF-Egr1 pathway: unleashing the apoptotic power of c-Myc.

Authors:  David N Boone; Stephen R Hann
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

8.  IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes.

Authors:  Myrianne Duré; Fernando Macian
Journal:  Mol Immunol       Date:  2008-11-05       Impact factor: 4.407

9.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

10.  EGR-2 is not required for in vivo CD4 T cell mediated immune responses.

Authors:  Hilda E Ramón; Pedro J Cejas; David LaRosa; Adeeb Rahman; John E Harris; Jidong Zhang; Christopher Hunter; Yongwon Choi; Laurence A Turka
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.